Intramyocardial Bridge in Sports Medicine: Proposal of a Possible Follow-Up Strategy in Asymptomatic Athletes

Roberto Palazzo1, Melissa Orlandi1, Federico Fu1

  • 1Sports Medicine Centre, Clinical and Experimental Medicine, University of Florence, 50134 Florence, Italy.

Insights

Athletes with intramyocardial bridges (MB) show reduced heart function during exercise, even if asymptomatic. A combined test of cardiopulmonary exercise (CPET) and heart imaging can detect this impairment.

Area of Science:

  • Cardiology
  • Sports Medicine
  • Diagnostic Imaging

Background:

  • Intramyocardial bridge (MB) is a coronary artery anomaly where a segment tunnels within the heart muscle.
  • While often asymptomatic, MB can lead to myocardial ischemia and is a concern for athletes.
  • Recent guidelines allow sports participation for athletes with MBs lacking high-risk features.

Purpose of the Study:

  • To assess the functional impact of MB in asymptomatic athletes using a novel combined provocative test.
  • To integrate Cardiopulmonary Exercise Testing (CPET) with stress echocardiography for myocardial deformation analysis.
  • To evaluate the diagnostic utility of this combined approach for identifying exercise-induced impairment.

Main Methods:

  • A cross-sectional case-control study involving 18 participants (9 with significant MB, 9 healthy controls).
  • Participants underwent resting echocardiography, Global Longitudinal Strain (GLS) assessment, and CPET.
  • Dynamic myocardial function and exercise capacity were quantified during stress.

Main Results:

  • No significant resting echocardiographic differences were found between MB athletes and controls.
  • During exercise, MB athletes exhibited significantly reduced GLS and ventricular twist compared to controls.
  • A notable loss of apical reserve was observed in the MB cohort under physical stress.

Conclusions:

  • The combined CPET and myocardial deformation analysis effectively identifies functional impairment in asymptomatic athletes with MB.
  • This integrated approach offers a superior follow-up strategy for managing MB athletes at risk of ischemic events.
  • The study highlights the importance of functional assessment beyond morphology for athletic clearance.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
342
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
493
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
1.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
488